Clinical Biochemist | Dual Master's in Digital Health and Public Health Management | COVID-19 Expert | Leader in Clinical Diagnostics | Published Scientist.
A study in Science Translational Medicine reveals that the risk of prolonged severe COVID-19 varies among immunosuppressed individuals. The research, led by Yijia Li, M.D., from Harvard Medical School, emphasizes the importance of understanding immune defects influencing persistent COVID-19 across various immunosuppressive conditions. #COVID19Research #Immunocompromised #SARSCoV2 #HealthStudy #Immunosuppression #MedicalResearch